Is Altimmune, Inc. (ALT) a Buy, Sell, or Hold?
Altimmune, Inc.
NASDAQ:ALT
$2.98 USD
$0.05 (1.71%)
- Volume
- 2.83M
- Average Volume
- 4.41M
- Market Capitalization
- $263.01M
- P/E Ratio
- -3.20
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $6.44
- Year Low
- $2.56
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $29.56
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
56
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
22
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 294.15K
ALT Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ALT Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Lawver Teri L | director | 2026-05-01 | A-Award | 2.82 | 2026-05-01 |
| Sohn Catherine A. | director | 2026-05-01 | A-Award | 2.82 | 2026-05-01 |
| Jorkasky Diane | director | 2026-05-01 | A-Award | 2.82 | 2026-05-01 |
| Schafer Klaus | director | 2026-05-01 | A-Award | 2.82 | 2026-05-01 |
| Pisano Wayne | director | 2026-05-01 | A-Award | 2.82 | 2026-05-01 |
| Hodges Philip | director | 2026-05-01 | A-Award | 2.82 | 2026-05-01 |
| GILL JOHN | director | 2026-05-01 | A-Award | 2.82 | 2026-05-01 |
| SAYARE MITCHEL | director | 2026-05-01 | A-Award | 2.82 | 2026-05-01 |
| GILL JOHN | director | 2026-04-06 | P-Purchase | 3.4076 | 2026-04-06 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2026-04-01 | P-Purchase | 3.1499 | 2026-04-01 |
| Durso Jerome Benedict | director, officer: President and CEO | 2026-04-01 | P-Purchase | 3.14 | 2026-04-01 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2026-03-06 | P-Purchase | 3.54 | 2026-03-09 |
| Durso Jerome Benedict | director, officer: President and CEO | 2026-03-06 | P-Purchase | 3.5395 | 2026-03-09 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-02-26 | A-Award | 4.46 | 2026-02-27 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-02-26 | A-Award | 0 | 2026-02-27 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2026-02-26 | A-Award | 4.46 | 2026-02-27 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2026-02-26 | A-Award | 0 | 2026-02-27 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-02-02 | M-Exempt | 0 | 2026-02-03 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-02-02 | F-InKind | 5.55 | 2026-02-03 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-31 | A-Award | 3.07 | 2026-02-03 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-30 | M-Exempt | 0 | 2026-02-03 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-30 | F-InKind | 5.6 | 2026-02-03 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-30 | M-Exempt | 0 | 2026-02-03 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-02-02 | M-Exempt | 0 | 2026-02-03 |
| Garg Vipin K | director | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| Garg Vipin K | director | 2026-01-31 | A-Award | 3.07 | 2026-02-02 |
| Garg Vipin K | director | 2026-01-30 | F-InKind | 5.6 | 2026-02-02 |
| Garg Vipin K | director | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-31 | A-Award | 3.07 | 2026-02-02 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-27 | M-Exempt | 0 | 2026-01-29 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-27 | F-InKind | 6.18 | 2026-01-29 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-27 | M-Exempt | 0 | 2026-01-29 |
| Garg Vipin K | director | 2026-01-27 | M-Exempt | 0 | 2026-01-29 |
| Garg Vipin K | director | 2026-01-27 | F-InKind | 6.18 | 2026-01-29 |
| Garg Vipin K | director | 2026-01-27 | M-Exempt | 0 | 2026-01-29 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-27 | M-Exempt | 0 | 2026-01-29 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-27 | F-InKind | 6.18 | 2026-01-29 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-27 | M-Exempt | 0 | 2026-01-29 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-25 | M-Exempt | 0 | 2026-01-27 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-25 | F-InKind | 5.5 | 2026-01-27 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-25 | M-Exempt | 0 | 2026-01-27 |
| Garg Vipin K | director | 2026-01-25 | M-Exempt | 0 | 2026-01-27 |
| Garg Vipin K | director | 2026-01-25 | F-InKind | 5.5 | 2026-01-27 |
| Garg Vipin K | director | 2026-01-25 | M-Exempt | 0 | 2026-01-27 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-25 | M-Exempt | 0 | 2026-01-27 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-25 | F-InKind | 5.5 | 2026-01-27 |
| Roberts M Scot | officer: Chief Scientific Officer | 2026-01-25 | M-Exempt | 0 | 2026-01-27 |
| Pisano Wayne | director | 2026-01-08 | P-Purchase | 4.082 | 2026-01-09 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-01 | M-Exempt | 0 | 2026-01-05 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-01 | F-InKind | 3.61 | 2026-01-05 |
| Jordt Raymond M | officer: Chief Business Officer | 2026-01-01 | M-Exempt | 0 | 2026-01-05 |
| Sohn Catherine A. | director | 2026-01-05 | P-Purchase | 4.2351 | 2026-01-05 |
| Jorkasky Diane | director | 2025-12-29 | P-Purchase | 3.8 | 2025-12-29 |
| GILL JOHN | director | 2025-12-23 | P-Purchase | 4.1 | 2025-12-23 |
| Durso Jerome Benedict | director | 2025-12-22 | P-Purchase | 4.1255 | 2025-12-22 |
| Durso Jerome Benedict | director, officer: CEO-elect | 2025-12-01 | A-Award | 4.93 | 2025-12-01 |
| Durso Jerome Benedict | director, officer: CEO-elect | 2025-12-01 | A-Award | 0 | 2025-12-01 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2025-11-11 | M-Exempt | 0 | 2025-11-12 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2025-11-11 | M-Exempt | 0 | 2025-11-12 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2025-11-11 | F-InKind | 4.28 | 2025-11-12 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2025-10-01 | A-Award | 3.87 | 2025-10-03 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2025-10-01 | A-Award | 0 | 2025-10-03 |
| Arbet-Engels Christophe | officer: Chief Medical Officer | 2025-10-01 | A-Award | 3.87 | 2025-10-03 |
| Arbet-Engels Christophe | officer: Chief Medical Officer | 2025-10-01 | A-Award | 0 | 2025-10-03 |
| Arbet-Engels Christophe | officer | 2025-10-01 | 0 | 2025-10-03 | |
| Sohn Catherine A. | director | 2025-09-25 | A-Award | 3.92 | 2025-09-29 |
| Durso Jerome Benedict | director | 2025-09-25 | A-Award | 3.92 | 2025-09-29 |
| Lawver Teri L | director | 2025-09-25 | A-Award | 3.92 | 2025-09-29 |
| Jorkasky Diane | director | 2025-09-25 | A-Award | 3.92 | 2025-09-29 |
| GILL JOHN | director | 2025-09-25 | A-Award | 3.92 | 2025-09-29 |
| GILL JOHN | director | 2022-01-06 | G-Gift | 0 | 2025-09-29 |
| Schafer Klaus | director | 2025-09-25 | A-Award | 3.92 | 2025-09-29 |
| SAYARE MITCHEL | director | 2025-09-25 | A-Award | 3.92 | 2025-09-29 |
| Hodges Philip | director | 2025-09-25 | A-Award | 3.92 | 2025-09-29 |
| Pisano Wayne | director | 2025-09-25 | A-Award | 3.92 | 2025-09-29 |
| Richardson Linda M | officer: Chief Commercial Officer | 2025-09-16 | A-Award | 3.63 | 2025-09-17 |
| Richardson Linda M | officer: Chief Commercial Officer | 2025-09-16 | A-Award | 0 | 2025-09-17 |
| Richardson Linda M | officer | 2025-09-16 | 0 | 2025-09-17 | |
| Jordt Raymond M | officer: Chief Business Officer | 2025-07-31 | A-Award | 3.14 | 2025-08-04 |
| Harris Matthew Scott | officer: Chief Medical Officer | 2025-07-31 | A-Award | 3.14 | 2025-08-04 |
| Roberts M Scot | officer: Chief Scientific Officer | 2025-07-31 | A-Award | 3.14 | 2025-08-04 |
| Sohn Catherine A. | director | 2025-03-17 | P-Purchase | 5.7845 | 2025-03-18 |
| WEAVER GREGORY L | officer: Chief Financial Officer | 2025-03-13 | P-Purchase | 5.1996 | 2025-03-14 |
| Harris Matthew Scott | officer: Chief Medical Officer | 2025-03-07 | G-Gift | 0 | 2025-03-11 |
| Lawver Teri L | director | 2025-02-24 | A-Award | 6.11 | 2025-02-26 |
| Lawver Teri L | director: | 2025-02-24 | 0 | 2025-02-26 | |
| Durso Jerome Benedict | director | 2025-02-24 | A-Award | 6.11 | 2025-02-25 |
| Durso Jerome Benedict | director: | 2025-02-24 | 0 | 2025-02-25 | |
| Sohn Catherine A. | director | 2025-02-06 | A-Award | 6.91 | 2025-02-07 |
| Garg Vipin K | director, officer: President and CEO | 2025-02-02 | M-Exempt | 0 | 2025-02-03 |
| Garg Vipin K | director, officer: President and CEO | 2025-02-02 | F-InKind | 6.64 | 2025-02-03 |
| Garg Vipin K | director, officer: President and CEO | 2025-02-01 | M-Exempt | 0 | 2025-02-03 |
| Garg Vipin K | director, officer: President and CEO | 2025-02-01 | F-InKind | 6.64 | 2025-02-03 |
| Garg Vipin K | director, officer: President and CEO | 2025-01-30 | M-Exempt | 0 | 2025-02-03 |
| Garg Vipin K | director, officer: President and CEO | 2025-01-31 | A-Award | 5.18 | 2025-02-03 |
| Garg Vipin K | director, officer: President and CEO | 2025-01-30 | F-InKind | 7 | 2025-02-03 |
| Garg Vipin K | director, officer: President and CEO | 2025-01-30 | M-Exempt | 0 | 2025-02-03 |
| Garg Vipin K | director, officer: President and CEO | 2025-02-02 | M-Exempt | 0 | 2025-02-03 |
| Garg Vipin K | director, officer: President and CEO | 2025-02-01 | M-Exempt | 0 | 2025-02-03 |
| Harris Matthew Scott | officer: Chief Medical Officer | 2025-02-02 | M-Exempt | 0 | 2025-02-03 |